Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3601-3610 of 11316

Edit search filters
  1. Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System

    Jacksonville, FL, Rochester, MN

  2. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil

    Jacksonville, FL

  3. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma

  4. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. HELP-HY: Health Education and sLeep Program in HYpertension

    Rochester, MN

  6. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3)

    Scottsdale/Phoenix, AZ

  7. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrent C. Diff

    Rochester, MN

  8. Atrial Fibrillation Screening and Education Study

    Rochester, MN

  9. A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

    Rochester, MN

  10. Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

    Rochester, MN

.

Mayo Clinic Footer